COS(=O)(=O)[O-].C[n+]1c2ccc(Cl)cc2nc2cc(-c3ccccc3)ccc21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?